Last updated on April 2019

'Palliative-D' Vitamin D to Palliative Cancer Patients

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Vitamin D Deficiency
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  1. Patients admitted to ASIH Stockholm Sdra or Stockholms Sjukhem.
  2. Incurable cancer patients with any type of cancer. They could have ongoing oncological treatment but only with palliative intention. No patients with ongoing oncological treatment with curative intended treated will be included.
  3. The life expectancy should be at least 3 months according to the clinical assessment of the study physician at the screening visit.
  4. The patient should have no cognitive failure, being able to comprehend oral and written information about the study.
  5. 25 OHD < 50 nmol/L.
  6. Men and women aged 18
  7. Signed 'informed consent'

Exclusion Criteria:

  1. Ongoing vitamin D supplementation at the time for inclusion.
  2. Serum level of 25-OH vitamin D3 <50 nmol/L
  3. Known sarkoidosis
  4. Treatment with tiazides or digoxin or digitoxin
  5. Primary hyperparathyroidism
  6. Hypercalcaemia (verified by a laboratory result younger than 2 month)
  7. Plans to leave the Stockholm county within 12 weeks of inclusion
  8. History of kidney stones
  9. Taking part of another clinical study involving drugs
  10. Hypersensitivity to cholecalciferol and/or any of the excipients
  11. Other criteria that could jeopardize the study or its intention as judged by the investigator
  12. Not being able to perform EORTC-QLQ-C15-PAL or ESAS

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.